GLPBio

Stem Cell

Research Areas

Products Related to Stem Cell(471)

  • GC73876 structure
    GC73876PTK7/β-catenin-IN-6
    CAS: 1219439-82-3

    PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC).

  • GC73954 structure
    GC73954BAY-593
    CAS: 2413020-56-9
    Purity: >99.00%

    BAY-593 is an orally active GGTase-I inhibitor.

  • GC73955 structure
    GC73955(7S)-BAY-593
    CAS: 2413068-25-2
    Purity: >99.00%

    (7S)-BAY-593 is the S-enantiomer of BAY-593.

  • GC73959 structure
    GC73959NF764
    Purity: >99.00%

    NF764 is a potent β-catenin (CTNNB1) degrader.

  • GC74091 structure
    GC74091Itraconazole-d9
    CAS: 1309272-50-1
    Purity: >97.00%

    Itraconazole-d9 is the deuterium labeled Itraconazole.

  • GC74115 structure
    GC74115YAP/TAZ inhibitor-3
    CAS: 2506273-81-8
    Purity: >99.00%

    YAP/TAZ inhibitor-3 (Compound 24) is a YAP/TAZ inhibitor.

  • GC74261 structure
    GC74261(R)-(+)-O-Demethylbuchenavianine
    CAS: 1364123-68-1
    Purity: >98.00%

    (R)-(+)-O-Demetlbuchenavianine is an inhibitor for Cyclin-dependent kinases (CDK).

  • GC74320 structure
    GC74320fStAx-35R TFA
    Purity: >97.00%

    fStAx-35R TFA is the drocarbon-stapled peptide. fStAx-35R TFA inhibits Wnt/β-catenin signaling pathway by disrupting the β-catenin-TCF interaction. fStAx-35R TFA can be used in cancer research.

  • GC74321 structure
    GC74321aStAx-35R TFA
    Purity: >98.00%

    aStAx-35R TFA, a stapled peptide, antagonizes nuclear form of β-catenin and inhibits Wnt signaling.

  • GC74343 structure
    GC74343Fz7-21S
    CAS: 2247635-24-9
    Purity: >98.00%

    Fz7-21S is a negative control of Fz7-21.

  • GC74412 structure
    GC74412xStAx-VHLL TFA
    Purity: >99.00%

    xStAx-VHLL TFA, a PROTAC, sustains β-catenin degradation and manifested strong inhibition of Wnt signaling. xStAx-VHLL TFA promotes β-catenin ubiquitination.

  • GC74473 structure
    GC74473Demcizumab
    CAS: 1243262-17-0
    Purity: >95.00%

    Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody.

  • GC74489 structure
    GC74489Tarextumab
    CAS: 1359940-55-8
    Purity: >96.00%

    Tarextumab (OMP-59R5) is an anti-Notch2/3 fully human IgG2 monoclonal antibody.

  • GC74579 structure
    GC74579Vantictumab
    CAS: 1345009-45-1
    Purity: >97.50%

    Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody.

  • GC78805 structure
    GC78805Zocilurtatug pelitecan
    CAS: 3058592-88-1
    Purity: >98%

    Zocilurtatug pelitecan (ZL-1310) is a blood-brain barrier-penetrating antibody-drug conjugate targeting DLL3.

  • GC78980 structure
    GC78980Rhodojaponin VI
    CAS: 37720-87-9
    Purity: >99.50%

    Rhodojaponin VI is an orally active diterpenoid compound found in hododendron molle G.

  • GC79063 structure
    GC79063TNKS-IN-1
    CAS: 59455-93-5
    Purity: >99.50%

    TNKS-IN-1 is a selective and potent tankyrase ( TNKS1 / TNKS2 ) inhibitor with IC 50 values of 7.9 nM and 8.7 nM.

  • GC79110 structure
    GC79110CK1-IN-5
    CAS: 1000340-33-9
    Purity: >99.00%

    CK1-IN-5 (compound B-AZ) is an inhibitor of CK1.

  • GC79111 structure
    GC79111CK2-TN03
    CAS: 313226-24-3
    Purity: >98.00%

    CK2-TN03 is an ATP-competitive casein kinase 2 ( CK2 ) inhibitor, with an IC 50 of 165 nM and a K i of 20 nM.

  • GC79112 structure
    GC79112PF-670462
    CAS: 950980-98-0
    Purity: >99.00%

    PF-670462 is a selective CKI ε/δ inhibitor.

  • GC79113 structure
    GC79113Casein Kinase II Substrate acetate
    Purity: >99.50%

    Casein Kinase II Substrate acetate is a casein kinase II ( CK2 ) peptide substrate that can be selectively phosphorylated by CK2 [1] .

  • GC79114 structure
    GC79114CCK1-specific peptide substrate acetate
    Purity: >98.00%

    CCK1-specific peptide substrate acetate is a biological active peptide.

  • GC79117 structure
    GC791178012–3246
    CAS: 421586-94-9
    Purity: >99.50%

    8012-3246 is a selective PLK2 inhibitor with an IC 50 of 774.5 nM.

  • GC79188 structure
    GC79188TAS1440
    CAS: 2098585-77-2
    Purity: >98.00%

    TAS1440 is an orally active LSD1/KDM1A inhibitor with a human IC 50 of 4.8 nM.